OraSure Technologies Inc

Find Ratings Reports
OSUR : NASDAQ : Health Care
$6.50 -0.01 | -0.15%
Today's Range: 6.41 - 6.57
Avg. Daily Volume: 831,000
07/26/16 - 4:00 PM ET

Financial Analysis


ORASURE TECHNOLOGIES INC's gross profit margin for the first quarter of its fiscal year 2016 has increased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. ORASURE TECHNOLOGIES INC is extremely liquid. Currently, the Quick Ratio is 5.85 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.

At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 4.61% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY16 Q1 FY15
Net Sales ($mil)29.0927.09
EBITDA ($mil)4.051.12
EBIT ($mil)2.7-0.29
Net Income ($mil)2.450.11


Balance Sheet Q1 FY16 Q1 FY15
Cash & Equiv. ($mil)102.2589.49
Total Assets ($mil)188.48177.64
Total Debt ($mil)0.00.0
Equity ($mil)163.02155.83


Profitability Q1 FY16 Q1 FY15
Gross Profit Margin74.4967.95
EBITDA Margin13.934.12
Operating Margin9.28-1.07
Sales Turnover0.650.62
Return on Assets5.570.63
Return on Equity6.440.72
Debt Q1 FY16 Q1 FY15
Current Ratio6.67.03
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q1 FY16 Q1 FY15
Shares outstanding (mil)55.4856.42
Div / share0.00.0
EPS0.040.0
Book value / share2.942.76
Institutional Own % n/a n/a
Avg Daily Volume831853.0559470.0

Valuation


HOLD. The current P/E ratio indicates a significant discount compared to an average of 62.82 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 25.05. To use another comparison, its price-to-book ratio of 2.21 indicates a discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 4.84. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, ORASURE TECHNOLOGIES INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
OSUR 36.06 Peers 62.82   OSUR 13.37 Peers 33.31

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

OSUR is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

OSUR is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
OSUR 48.07 Peers 29.14   OSUR 0.37 Peers 1.03

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

OSUR is trading at a discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

OSUR trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
OSUR 2.21 Peers 4.84   OSUR 1700.00 Peers 159.18

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

OSUR is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

OSUR is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
OSUR 2.96 Peers 4.71   OSUR 10.63 Peers 20.16

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

OSUR is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

OSUR significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades